Lauren Glenn serves as the Vice President of Clinical Operations at Spur Therapeutics, leveraging over two decades of experience in the biopharmaceutical industry. Her career includes leadership positions at SwanBio Therapeutics, uniQure, and Achillion Pharmaceuticals, where she specialized in managing global clinical trials for rare diseases and advanced gene therapies. She holds a BS from The College of New Jersey.
Her career is distinguished by a consistent focus on operational leadership for clinical trials in pioneering medical fields, particularly gene therapy.